Literature DB >> 8521478

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

R Langenbach1, S G Morham, H F Tiano, C D Loftin, B I Ghanayem, P C Chulada, J F Mahler, C A Lee, E H Goulding, K D Kluckman, H S Kim, O Smithies.   

Abstract

Cyclooxygenases 1 and 2 (COX-1 and COX-2) are key enzymes in prostaglandin biosynthesis and the target enzymes for the widely used nonsteroidal anti-inflammatory drugs. To study the physiological roles of the individual isoforms, we have disrupted the mouse Ptgs1 gene encoding COX-1. Homozygous Ptgs1 mutant mice survive well, have no gastric pathology, and show less indomethacin-induced gastric ulceration than wild-type mice, even though their gastric prostaglandin E2 levels are about 1% of wild type. The homozygous mutant mice have reduced platelet aggregation and a decreased inflammatory response to arachidonic acid, but not to tetradecanoyl phorbol acetate. Ptgs1 homozygous mutant females mated to homozygous mutant males produce few live offspring. COX-1-deficient mice provide a useful model to distinguish the physiological roles of COX-1 and COX-2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521478     DOI: 10.1016/0092-8674(95)90126-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  229 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Why there are two cyclooxygenase isozymes.

Authors:  W L Smith; R Langenbach
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Aspirin and other anti-inflammatory drugs.

Authors:  S J Vane
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  Not a mouse stirring: deletion of the EP2 and love's labor's lost.

Authors:  S Austin; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.

Authors:  D Saha; P K Datta; H Sheng; J D Morrow; M Wada; H L Moses; R D Beauchamp
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

Review 6.  Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.

Authors:  P L McGeer
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

7.  Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.

Authors:  V Puigneró; J Queralt
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

8.  Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Authors:  Elzbieta Kolaczkowska; Barbara Plytycz; Bernd Arnold; Helene Piccard; Ghislain Opdenakker
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

9.  Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

Authors:  James C Bonner; Annette B Rice; Jennifer L Ingram; Cindy R Moomaw; Abraham Nyska; Alyce Bradbury; Alisha R Sessoms; Patricia C Chulada; Daniel L Morgan; Darryl C Zeldin; Robert Langenbach
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 10.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.